Could this startup have the cure for obesity? Meet Pep2Tango Therapeutics!
Versant Ventures has introduced Pep2Tango Therapeutics Inc., a biotechnology startup dedicated to pioneering next-generation therapies for weight loss. The company has secured significant, albeit undisclosed, funding to advance the development of its innovative unimolecular tetra-receptor agonist peptides designed to treat obesity and its associated conditions. Addressing limitations of GLP-1 therapies While GLP-1-based therapies have shown […]